Alternative Mitochondrial Electron Transfer as a Novel Strategy for Neuroprotection

作者: Yi Wen , Wenjun Li , Ethan C. Poteet , Luokun Xie , Cong Tan

DOI: 10.1074/JBC.M110.208447

关键词:

摘要: Neuroprotective strategies, including free radical scavengers, ion channel modulators, and anti-inflammatory agents, have been extensively explored in the last 2 decades for treatment of neurological diseases. Unfortunately, none neuroprotectants has proved effective clinical trails. In current study, we demonstrated that methylene blue (MB) functions as an alternative electron carrier, which accepts electrons from NADH transfers them to cytochrome c bypasses complex I/III blockage. A de novo synthesized MB derivative, with redox center disabled by N-acetylation, had no effect on mitochondrial activities. increases cellular oxygen consumption rates reduces anaerobic glycolysis cultured neuronal cells. is protective against various insults vitro at low nanomolar concentrations. Our data indicate a unique mechanism fundamentally different traditional antioxidants. We examined effects two animal models dramatically attenuates behavioral, neurochemical, neuropathological impairment Parkinson disease model. Rotenone caused severe dopamine depletion striatum, was almost completely rescued MB. rotenone I-III inhibition overproduction. induced loss nigral dopaminergic neurons, attenuated addition, significantly reduced cerebral ischemia reperfusion damage transient focal The present study indicates rerouting transfer or similar molecules provides novel strategy neuroprotection both chronic acute diseases involving dysfunction.

参考文章(54)
F Brunner, K Schmidt, B Mayer, Novel actions of methylene blue. European Heart Journal. ,vol. 14, pp. 22- 26 ,(1993)
Amanpreet S. Dhillon, G. Lester Tarbutton, Jeffrey L. Levin, George M. Plotkin, Larry K. Lowry, J. Torey Nalbone, Sara Shepherd, Pesticide/environmental exposures and Parkinson's disease in East Texas. Journal of Agromedicine. ,vol. 13, pp. 37- 48 ,(2008) , 10.1080/10599240801986215
Ranjita Betarbet, Todd B. Sherer, Gillian MacKenzie, Monica Garcia-Osuna, Alexander V. Panov, J. Timothy Greenamyre, Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nature Neuroscience. ,vol. 3, pp. 1301- 1306 ,(2000) , 10.1038/81834
Ian A. Trounce, Yoon L. Kim, Albert S. Jun, Douglas C. Wallace, Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods in Enzymology. ,vol. 264, pp. 484- 509 ,(1996) , 10.1016/S0076-6879(96)64044-0
Giorgio Lenaz, Romana Fato, Alessandra Baracca, Maria Luisa Genova, Mitochondrial quinone reductases: complex I. Methods in Enzymology. ,vol. 382, pp. 3- 20 ,(2004) , 10.1016/S0076-6879(04)82001-9
J.Timothy Greenamyre, Gillian MacKenzie, Tsung-I Peng, Stacy E. Stephans, Mitochondrial Dysfunction in Parkinson’s Disease Biochemical Society Symposia. ,vol. 66, pp. 85- 97 ,(1999) , 10.1042/BSS0660085
Byoung Boo Seo, Eiko Nakamaru-Ogiso, Terence R. Flotte, Akemi Matsuno-Yagi, Takao Yagi, In Vivo Complementation of Complex I by the Yeast Ndi1 Enzyme POSSIBLE APPLICATION FOR TREATMENT OF PARKINSON DISEASE Journal of Biological Chemistry. ,vol. 281, pp. 14250- 14255 ,(2006) , 10.1074/JBC.M600922200
Rebecka Klintenberg, Joris Arts, Minke Jongsma, Håkan Wikström, Lars Gunne, Per E. Andrén, Motor effects of a dopamine stabilizer (GMC1111) in primate models of Parkinson and hemiparkinsonism. European Journal of Pharmacology. ,vol. 459, pp. 231- 237 ,(2003) , 10.1016/S0014-2999(02)02817-0